Post Archive by Month

To address malaria outbreaks in Africa, two approved malaria vaccines have been deployed in eight countries, with measurable success.
As 2024 progresses, additional African countries will launch malaria vaccination programs.
Additionally, passive immunization products, which have been tested for years, are now conducting late-stage clinical trials.
These experimental monoclonal antibody therapies offer significant value in protecting children, pregnant women, and immunocompromised individuals from contracting malaria.

As of April 2024, the World Health Organization (WHO) has determined that nearly all circulating SARS-CoV-2 variants reported in publicly available databases are JN.1 derived coronavirus variants.
On April 26, 2024, the WHO stated in a media release that virus evolution is expected to continue from JN.1, and future formulations of COVID-19 vaccines should aim to induce enhanced neutralizing antibody responses to JN.1 and its descendent lineages.
The WHO says the regular review of the available vaccine effectiveness evidence (VE) is critical to assessing future versions.

Physical, psychiatric, and cognitive problems seen in those discharged to long-term acute care hospitals

For decades, antibiotics have been a mainstay of treatments for urinary tract infections (UTIs). Still, the growing threat of antibiotic resistance has limited clinicians' options to control infections effectively.
A 2022 World Health Organization surveillance report found that the most common cause of UTIs is resistance to first—and second-line antibiotics.
Research indicates that 40% of women in the United States will develop a UTI at some point in their lifetime.

In recognition of World Malaria Day 2024, various countries are reporting increased cases related to international travelers and actions to prevent further outbreaks.
The World Health Organisation (WHO) recently reported that global malaria cases were estimated at 249 million in 2022, an increase of about 2% from 2021.

Findings based on review of national versus WHO guidelines

A study published today by The Lancet has revealed that global immunization efforts have saved an estimated 154 million lives over the past 50 years.
Most lives saved were those of infants, with 101 million lives saved.
The study, led by the World Health Organization (WHO), found that vaccination against 14 diseases has reduced infant deaths by 40% globally.

For several decades, a century-old vaccine has been used to treat a specific type of bladder cancer. In the 1970s, the Bacillus Calmette-Guérin (BCG) vaccine was approved as an immunotherapeutic treatment for bladder cancer patients.
Since then, various BCG vaccines have become the standard therapy for treating high-risk nonmuscle-invasive bladder cancer (NMIBC) patients to prevent the recurrence and progression of the disease.

In April 2024, the United States observes the 15th Annual Oral Cancer Awareness Month, which emphasizes the significance of preventing human papillomavirus (HPV)- related oral cancers.
Projections estimate an upward trend for the next decade, with predictions greater than 30,000 oral cancer cases annually by 2029.
Research shows that more than 90% of oropharyngeal cancer cases are linked to HPV 16.
As of 2023, oropharyngeal and oral cavity cancers impact far more men than women.